A Long-term Extension Clinical Study of TLL-018 in Patients With Rheumatoid Arthritis

Clinical trial NCT06887127 · RECRUITING

Trial details

NCT number: NCT06887127
Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2025-03-10
Primary completion: 2026-12-31
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.